News Daily News LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk group. Todd Neale September 30, 2025
Presentation ESC 2025 ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation Presenter: Jonas Oldgren August 30, 2025
Presentation ESC 2025 POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients Presenter: Henning Bundgaard August 29, 2025
Presentation ESC 2025 AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation Presenter: Rohan Wijesurendra August 29, 2025
Presentation Controversies and Advances 2025 One Size Does Not Fit All: Only Selected Patients Should Go For AF Ablation Presenter: Sanjay Dixit January 31, 2025
Presentation Controversies and Advances 2025 Debate: In 2025, Who Should Get Catheter Ablation for Atrial Fibrillation? Presenter: Edward P. Gerstenfeld January 31, 2025
News Conference News TCT 2025 What’s Going to Be Hot at TCT 2025 By Michael O'Riordan October 09, 2025
News Daily News LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke By Todd Neale September 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2025 By Michael O'Riordan September 30, 2025
News Conference News HFSA 2025 CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF By Yael L. Maxwell September 29, 2025
News Daily News Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE By Michael O'Riordan September 26, 2025